I agree that this site is using cookies. You can find further informations here.
X
van der Plas, Johan L.
83  results:
Search for persons X
?
1

Safety, reactogenicity and immunogenicity of an intranasal ..:

van der Plas, Johan L. ; Haijema, Bert-Jan ; Leenhouts, Kees...
Vaccine.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Immunosuppression by hydroxychloroquine: mechanistic proof ..:

in 't Veld, Aliede E. ; Grievink, Hendrika W. ; van der Plas, Johan L....
Immunologic Research.  71 (2023)  4 - p. 617-627 , 2023
Link: https://doi.org/10.1007/..
 
?
3

A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐S..:

Yu, Hui Jing ; Thijssen, Eva ; van Brummelen, Emilie...
Movement Disorders.  37 (2022)  7 - p. 1416-1424 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Viral clearance, pharmacokinetics and tolerability of ensov..:

Prins, Manon L. M. ; van der Plas, Johan L. ; Vissers, Maurits F. J. M....
British Journal of Clinical Pharmacology.  89 (2022)  3 - p. 1105-1114 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Accelerating vaccine trial conduct in a pandemic with a hot..:

van der Plas, Johan L. ; van Esdonk, Michiel J. ; Kamerling, Ingrid M. C..
Clinical and Translational Science.  14 (2021)  6 - p. 2391-2398 , 2021
Link: https://doi.org/10.1111/..
 
?
6

First-in-human administration of a live-attenuated RSV vacc..:

Verdijk, Pauline ; van der Plas, Johan L. ; van Brummelen, Emilie M.J....
Vaccine.  38 (2020)  39 - p. 6088-6095 , 2020
Link: https://doi.org/10.1016/..
 
?
7

How to expedite early‐phase SARS‐CoV‐2 vaccine trials in pa..:

van der Plas, Johan L. ; Roestenberg, Meta ; Cohen, Adam F..
British Journal of Clinical Pharmacology.  87 (2020)  5 - p. 2167-2169 , 2020
Link: https://doi.org/10.1111/..
 
?
8

Prevalent levels of RSV serum neutralizing antibodies in he..:

Van Der Plas, Johan L. ; Verdijk, Pauline ; Van Brummelen, Emilie M. J....
Human Vaccines & Immunotherapeutics.  16 (2019)  6 - p. 1322-1326 , 2019
Link: https://doi.org/10.1080/..
 
?
9

Self-reported painful joint count and assessor-reported ten..:

Kroon, Féline P B ; Damman, Wendy ; van der Plas, Johan L...
Rheumatology.  59 (2019)  5 - p. 1094-1098 , 2019
Link: https://doi.org/10.1093/..
 
?
10

Immunosuppression by hydroxychloroquine: mechanistic proof ..:

in 't Veld, Aliede E ; Grievink, Hendrika W ; van der Plas, Johan L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945836/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Viral clearance, pharmacokinetics and tolerability of ensov..:

Prins, Manon L. M ; van der Plas, Johan L ; Vissers, Maurits F. J. M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875039/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

First-in-human administration of a live-attenuated RSV vacc..:

Verdijk, Pauline ; van der Plas, Johan L ; van Brummelen, Emilie M J...
0264-410X.  , 2020
Link: https://dspace.library.u..
 
?
13

Self-reported painful joint count and assessor-reported ten..:

Kroon, Féline P B ; Damman, Wendy ; van der Plas, Johan L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850158/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

Prevalent levels of RSV serum neutralizing antibodies in he..:

Van Der Plas, Johan L ; Verdijk, Pauline ; Van Brummelen, Emilie M. J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482755/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

Prevalent levels of RSV serum neutralizing antibodies in he..:

Johan L. Van Der Plas ; Pauline Verdijk ; Emilie M. J. Van Brummelen...
http://dx.doi.org/10.1080/21645515.2019.1688040.  , 2020
Link: https://doi.org/10.1080/..
 
1-15